BSE filing, NSE: WELTI. Summary written from the filing by ALFA Finder's alert engine.
Welterman International Ltd: key numbers
- Share price
- ₹19.00
- Market cap
- ₹8.44 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-0.50 Cr
- P/E (TTM)
- -16.5×Sector 49.5×
- Promoter holding
- 45.34%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Welterman International Ltd
All →Welterman International Annual General Meeting
Welterman International Ltd filed the voting results of its 34th Annual General Meeting, where shareholders adopted the audited financial statements. All resolutions were passed.
Welterman International Annual Report
Welterman International filed its Annual Report for FY 2025-26 under SEBI Reg 34(1). The filing also includes the Notice of the 34th AGM dated 30 September 2026.
Welterman International Other Announcement
Welterman International Ltd notified book closure from 24–30 September 2026 for its 34th AGM. This is a routine regulatory intimation with no financial or business impact.
Welterman International Annual General Meeting
Welterman International has scheduled its 34th AGM for 30 September 2026 with e-voting. Book closure runs 24–30 September 2026.
Welterman International Annual General Meeting
Welterman International scheduled its 34th Annual General Meeting for September 30, 2026, and approved the notice and Board's report for F.Y. 2025-26.
Welterman International Board Meeting Date
Welterman International scheduled a board meeting for August 25, 2026. The meeting will address procedural items for the upcoming 34th Annual General Meeting.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.